NCT07088731View on ClinicalTrials.gov

Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Cervical Carcinoma
Interventions
DRUG

Sintilimab

neoadjuvent chemotherapy plus sintilimab for 2 cycles followed by radical surgery

RADIATION

Concurrent chemo-radiotherapy

EBRT+BT+cisplatin

Trial Locations (1)

Unknown

Department of Gynecological Oncology, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER